Latest Breaking News On - Patients with her2 positive early breast cancer - Page 1 : comparemela.com

Maria Hafez, MD, discusses the design of, and outcomes from, the phase 3 FeDeriCa trial in patients with HER2-positive early breast cancer.

Maria-hafez
Sidney-kimmel-medical-college
Thomas-jefferson-university
Clinical-breast-cancer-research
D
Federica-trial
Patients-with-her2-positive-early-breast-cancer